Refining the spectrum of neuronal intranuclear inclusion disease: A case report
Cupidi, Chiara; Dijkstra, Anke A.; Melhem, Shami; Vernooij, Meike W.; Severijnen, Lies Anne; Hukema, Renate K.; Rozemuller, Annemieke J.M.; Neumann, Manuela; Van Swieten, John C.; Seelaar, Harro
(2019) Journal of Neuropathology and Experimental Neurology, volume 78, issue 7, pp. 665 - 670
(Article)
Abstract
Neuronal intranuclear inclusion disease (NIID) is a rare heterogeneous progressive neurodegenerative disease characterized by the presence of eosinophilic hyaline intranuclear inclusions in neuronal and glial cells of the CNS, peripheral cells of the autonomic nervous system, visceral organs and skin. The clinical presentation is broadly heterogeneous and includes limb weakness,
... read more
dementia, seizures, ataxia, and parkinsonism. High-intensity signal in the corticomedullary junction on brain MRI is a characteristic finding in NIID. We describe a 65-year-old patient presenting with mild cognitive impairment, evolving in dementia with behavioral disturbances and parkinsonism. Brain MRI showed mild global cortical atrophy, more pronounced in the cingulate and temporal cortex and mild leukoaraiosis, but no high-intensity signal in corticomedullary junction on diffusion weighted imaging. Neuropathological examination showed p62- and optineurin-positive neuronal intranuclear inclusions in the hippocampus and in some subcortical structures. Glial cells did not present any intranuclear inclusions, and no spongiotic changes proximal to the U-fibers or diffuse myelin pallor were disclosed in the white matter. We report on a case with pathological features of NIID showing different neuroimaging and pathological findings. We noted an absence of typical MRI abnormalities, lack of intranuclear inclusions in glial cells, and prominent involvement of hippocampal neurons, refining the clinico-pathological spectrum of the disease.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: Dementia, Intranuclear inclusions, Neuronal intranuclear inclusion disease, Optineurin, P62, Pathology and Forensic Medicine, Neurology, Clinical Neurology, Cellular and Molecular Neuroscience
ISSN: 0022-3069
Publisher: Lippincott Williams and Wilkins
Note: Funding Information: Send correspondence to: Harro Seelaar, MD, PhD, Department of Neurology, Erasmus University Medical Center, Room Ee 2291, Dr Molewaterplein 40, 3015 CD Rotterdam, The Netherlands; E-mail: h.seelaar@ erasmusmc.nl Research was funded by ZonMw (funding 733051024). Publisher Copyright: © 2019 American Association of Neuropathologists, Inc. All rights reserved. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
(Peer reviewed)